United States · 
Who invested in Inviragen?
Inviragen's investors include Venture Investors, Bio*One Capital, Charter Life Sciences and Phillip Private Equity.
United States · Series A startup
Who invested in Inviragen
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2009, from 1 source
- Latest round
- Series A, $15MOct 2009
- Investors
- 4
The rounds
- Oct 2009Series A$15M
Reported by inviragen.comSEC filing: $4.4M sold, first sale Sept 2009
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
Bio*One CapitalCorporate VC1round
Charter Life SciencesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Inviragen
How much has Inviragen raised?
Inviragen has raised $15M across 1 round since 2009.
When did Inviragen last raise?
Inviragen's most recent round was a Series A of $15M in Oct 2009.
What was Inviragen's biggest round?
Its most recent round, $15M in Oct 2009, is also its largest on record.
Who backed Inviragen first?
Inviragen's first round on record, in Oct 2009, was backed by Venture Investors, Bio*One Capital and Charter Life Sciences and 1 others.
What stage is Inviragen at?
Inviragen's latest named round is a Series A, in Oct 2009.
Where is Inviragen based?
Inviragen is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.